Related to the previous post no doubt, three years ago Glaxo reorganized its R&D department into smaller, presumably more empowered and entrepreneurial units (called DPUs) to hopefully improve the level of success. The catch? The Discovery Performance Units are evaluated every three years to determine how well they've met milestones.
If they haven't met their goals? Then they can lose funding, be disbanded and reassigned to other projects. It's the sink or swim approach to R&D. The first three year cycle evaluation is upon us so we will get some idea as to how this is actually working -- or if it is working. Some rivals say the three year time line is too short. We shall see.
Posted by Bruce Lehr Dec 4th 2011.